Assenagon Asset Management S.A. Axogen, Inc. Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Axogen, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,289,072 shares of AXGN stock, worth $30.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,289,072

Previous 1,023,122 25.99%

Holding current value

$30.5 Million

Previous $11.1 Million 107.18%

% of portfolio

0.04%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$10.77 - $17.84 $2.86 Million - $4.74 Million	265,950 Added 25.99%	1,289,072 $23 Million
Q2 2025 Jul 11, 2025	BUY	$9.29 - $17.81 $203,497 - $390,128	21,905 Added 2.19%	1,023,122 $11.1 Million
Q1 2025 Apr 15, 2025	BUY	$14.56 - $20.11 $2.54 Million - $3.51 Million	174,681 Added 21.13%	1,001,217 $18.5 Million
Q4 2024 Jan 14, 2025	SELL	$12.47 - $17.19 $6.04 Million - $8.33 Million	-484,570 Reduced 36.96%	826,536 $13.6 Million
Q3 2024 Oct 23, 2024	BUY	$7.52 - $14.69 $2,218 - $4,333	295 Added 0.02%	1,311,106 $18.4 Million

Q2 2024 Jul 18, 2024	BUY	$5.67 - $8.06 $7.08 Million - $10.1 Million	1,248,823 Added 2014.62%	1,310,811 $9.49 Million
Q3 2023 Nov 06, 2023	SELL	$4.68 - $9.26 $1.02 Million - $2.01 Million	-216,918 Reduced 77.77%	61,988 $309,000
Q2 2023 Jul 25, 2023	SELL	$8.5 - $10.38 $950,929 - $1.16 Million	-111,874 Reduced 28.63%	278,906 $2.55 Million
Q1 2023 Apr 18, 2023	SELL	$7.53 - $10.95 $147,008 - $213,776	-19,523 Reduced 4.76%	390,780 $3.69 Million
Q4 2022 Jan 12, 2023	SELL	$9.44 - $13.09 $1 Million - $1.39 Million	-105,943 Reduced 20.52%	410,303 $4.1 Million
Q2 2022 Jul 27, 2022	SELL	$6.99 - $10.0 $1.19 Million - $1.7 Million	-170,254 Reduced 24.8%	516,246 $4.23 Million
Q1 2022 Apr 25, 2022	BUY	$7.26 - $10.7 $1.27 Million - $1.87 Million	174,770 Added 34.15%	686,500 $5.45 Million
Q4 2021 Feb 01, 2022	BUY	$8.8 - $16.0 $1.09 Million - $1.99 Million	124,206 Added 32.05%	511,730 $4.8 Million
Q3 2021 Oct 19, 2021	SELL	$15.23 - $21.72 $1.94 Million - $2.76 Million	-127,253 Reduced 24.72%	387,524 $6.12 Million
Q2 2021 Jul 15, 2021	BUY	$17.8 - $23.5 $8.86 Million - $11.7 Million	497,589 Added 2894.98%	514,777 $11.1 Million
Q1 2021 Apr 26, 2021	SELL	$17.18 - $22.6 $5,789 - $7,616	-337 Reduced 1.92%	17,188 $348,000
Q4 2020 Feb 01, 2021	SELL	$11.5 - $17.96 $851,701 - $1.33 Million	-74,061 Reduced 80.86%	17,525 $313,000
Q3 2020 Oct 07, 2020	SELL	$10.62 - $13.12 $1.37 Million - $1.69 Million	-129,067 Reduced 58.49%	91,586 $1.07 Million
Q2 2020 Jul 21, 2020	BUY	$7.35 - $10.81 $1.62 Million - $2.39 Million	220,653 New	220,653 $2.04 Million

Others Institutions Holding AXGN

# of Institutions

186

Shares Held

41.6M

Call Options Held

86.4K

Put Options Held

14.3K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $1B
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Axogen, Inc. Transaction History